Krebs Biochemicals and Industries Limited — Board Meeting, 21-05-2026: Outcome of Board Meeting

Krebs Biochemicals' board meeting approved audited financial results for the quarter and financial year. The company reported a Q4 revenue of Rs 6.81 Cr with a Rs 2.34 Cr loss. For FY26, revenue was Rs 23.73 Cr, with a Rs 16.93 Cr loss. Operations at the Vizag plant remain closed since Feb 2025 due to a pollution board order.